Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
The BEF NETUEs Guide available now
Aids practitioners treating competition horses

The British Equine Federation (BEF) National Therapeutic Use Exemptions (NETUEs) Guide is now available to help practitioners who are treating horses under BEF or FEI regulations.

At FEI events, if a horse needs treatment, permission must be obtained from the Veterinary Delegate or, if it is a major event, the Veterinary Commission.

In competitions under national rules, however, there is no Veterinary Delegate equivalent and the Person Responsible (PR) must instead decide as to whether a horse that has been treated with a prohibited substance will compete.

At national level, the PR for a horse which requires treatment with a Controlled Medication Substance at or close to competition, should discuss the competition with the treating vet so that, if possible, medications can be used that will no longer be present in the horse's system by the time of competition.

When a Controlled Medication Substance is administered, the treating vet should complete a National Equine Therapeutic Use Exemption (NETUE) Medication form, and the PR then has ten working days with which to apply for an NETUE in full, using the BEFAR NETUE form.

The BEF Guide is available in full here.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.